The Asia Pacific Pediatric Perfusion Market would witness market growth of 6.6% CAGR during the forecast period (2023-2030).
Innovations in technology have been essential in enhancing pediatric perfusion's capabilities. Perfusion machines have grown more sophisticated, enabling precise control of parameters such as blood flow, temperature, and oxygenation. The miniaturization of equipment and the development of pediatric-specific components have made it feasible to cater to the unique requirements of pediatric patients, regardless of their age or size.
Moreover, monitoring and data management have made significant strides, enhancing the ability to monitor a child's status in real-time. This not only bolsters the safety of pediatric cardiac surgeries but also empowers perfusionists to make prompt adjustments as needed during the procedure, ultimately benefiting patient outcomes. Oxygenators, a critical component of perfusion circuits, have also experienced notable advancements. Oxygenators are responsible for the removal of carbon dioxide from the patient's blood and the replenishment of oxygen. In the realm of pediatric perfusion, these oxygenators must be adapted to the smaller blood volumes characteristic of young patients.
Thailand's emergence as a leading destination for medical tourism has significantly contributed to the demand for these services. The country's well-established healthcare infrastructure and expertise in pediatric cardiac care have attracted patients from neighboring countries and beyond. Hospitals in Bangkok, such as Bumrungrad International Hospital and Samitivej Children's Hospital, are known for their pediatric cardiac units and perfusion services. The market in China, India, and Thailand continues to evolve to meet the needs of their populations and medical tourists, underlining the critical role of these countries in the growth of pediatric cardiac care services in Asia.
The China market dominated the Asia Pacific Pediatric Perfusion Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $54,345.3 Thousands by 2030. The Japan market is exhibiting a CAGR of 5.9% during (2023 - 2030). Additionally, The India market would experience a CAGR of 7.2% during (2023 - 2030).
Based on End-use, the market is segmented into Hospitals, Cardiac Centers, and Others. Based on Product, the market is segmented into Pediatric Oxygenators, Pediatric Cannulae, Pediatric Blood Pumps, Pediatric Arterial Filters, Monitoring Systems and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Global Pediatric Perfusion Market is Predict to reach $801.8 Million by 2030, at a CAGR of 5.8%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, LivaNova PLC, Terumo Corporation, BL Lifesciences (BL group of family companies), Cardinal Health, Inc., EUROSETS S.R.L. (GVM Care Research), Getinge AB, Koninklijke Philips N.V., Nonin Medical, Inc. and GE HealthCare Technologies, Inc.
By End Use
By Product
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 